ARTINIS MEDICAL SYSTEMS BV

Their core work

Artinis Medical Systems is a Dutch SME that designs and manufactures near-infrared spectroscopy (fNIRS) devices used to measure brain activity and physiological signals. Their equipment is deployed in neuroscience research — from studying infant brain development to measuring subconscious consumer decision-making processes. In H2020, they serve as a technology provider, supplying biometric measurement hardware and expertise to research consortia focused on neurophysiology and neuro-business applications.

What they specialise in

How they've shifted over time

With all three projects starting in 2018-2019, the timeline is too compressed to show a dramatic shift. However, the data reveals a broadening pattern: MOTION and INFANS ground Artinis in clinical and developmental neuroscience, while RHUMBO extends their fNIRS technology into commercial neuro-business applications. The emergence of machine learning and mixed reality keywords in their recent portfolio suggests a move from pure physiological measurement toward data-driven interpretation and applied consumer contexts.

Artinis is expanding from clinical neuroscience instrumentation toward commercial applications of brain measurement — neuro-marketing, consumer research, and AI-augmented biosignal analysis — which signals growing interest in industry-facing use cases.

How they like to work

Artinis participates exclusively as a partner, never as coordinator — consistent with their role as a specialist equipment provider that contributes technology to researcher-led consortia. Across three MSCA training networks, they have worked with 25 unique partners in 11 countries, indicating they are well-connected but not driving project agendas. Their value proposition to consortia is clear: they bring commercial-grade fNIRS hardware and applied measurement expertise that academic partners typically cannot provide in-house.

Artinis has built a network of 25 partners across 11 countries through three MSCA training networks, giving them broad European connections in the neuroscience research community. Their partnerships span academic institutions and research hospitals focused on brain measurement and neurophysiology.

What sets them apart

Artinis occupies a rare niche as a commercial fNIRS manufacturer embedded in academic research networks. Unlike most instrument companies that simply sell equipment, they actively participate in training networks — hosting early-stage researchers and co-developing measurement protocols. For consortium builders, they offer a direct bridge between laboratory neuroscience and market-ready measurement devices, which is valuable for projects requiring validated, portable brain monitoring technology.

Highlights from their portfolio

• INFANS
  Largest funding (EUR 531K) and most clinically significant — developing integrated EEG+fNIRS assessment tools for neonatal brain safeguarding.
• RHUMBO
  Represents Artinis's push beyond clinical neuroscience into neuro-business, combining biometric signals with machine learning to predict consumer decisions in mixed reality.